Persistent, low-grade activation of the immune system characterized by sustained elevation of proinflammatory Cytokines (Interleukin-6, TNF, IL-1β) typically lasting weeks to years without proper resolution. Distinguished from acute inflammation by duration (>3 weeks), intensity (subclinical elevation rather than dramatic spike), absence of resolution phase signals (Specialized pro-resolving mediators), and failure to restore tissue homeostasis. Represents chronically activated ancestral survival programs operating in contexts they were never designed for.
Think of your immune system as a fire department. Acute inflammation is like responding to a house fire: trucks arrive with sirens blaring, firefighters pour water on the flames (inflammatory cytokines flood the site), the fire is extinguished, cleanup crews restore order (resolution mediators), and everyone goes home. The whole operation takes hours to days.
Chronic inflammation is when the fire department never leaves. Maybe there's a persistent smoldering in the walls (gut dysbiosis), or someone keeps throwing matches (processed food), or the smoke detectors are oversensitive (stress-primed immune cells). The firefighters are still there, hoses still running at low pressure, foam still spraying—but it's not the dramatic five-alarm response anymore. It's three firefighters standing around with their equipment idling, 24/7, for months or years. The sirens are off, but the engines never shut down.
The problem isn't the initial response—that's what firefighters are for. The problem is they never got the "all clear" signal to pack up and leave. Meanwhile, the constant low-grade water damage (inflammatory mediators) slowly destroys the foundation of the house (tissues), the electricity bill skyrockets (metabolic cost), and the neighbors (other organ systems) can't sleep because of the engine noise (systemic inflammation disrupting brain function, sleep, mood). Eventually, the house becomes structurally unsound not from the original fire, but from months of "help" that never ended.
Chronic inflammation results from failure to transition from inflammatory initiation to resolution of inflammation. The molecular cascade involves:
Initiation and Perpetuation:
-
Persistent exposure to inflammatory triggers:
-
Pattern recognition and signal amplification:
-
Cytokine production cascade:
Resolution Failure:
4. Impaired resolution mechanisms:
- Metabolic reprogramming:
Neural-Immune Interface:
6. Brain penetration:
-
Neurotransmitter disruption:
-
Insula dysfunction:
graph TD
A[Chronic Triggers] --> B[TLR4/NLRP3 Activation]
B --> C["NF-κB Nuclear Translocation"]
C --> D["IL-1β, IL-6, TNF Production"]
D --> E[Systemic Effects]
D --> F[CNS Effects]
E --> G[Insulin Resistance]
E --> H[Endothelial Dysfunction]
E --> I[Muscle Catabolism]
F --> J[IDO Activation]
J --> K["Tryptophan → Kynurenine"]
K --> L["KYNA + Quinolinic Acid"]
L --> M[Glutamate/NMDA Dysfunction]
F --> N[Insula Dysfunction]
N --> O[Loss of Interoceptive Integration]
O --> P[Depression, Pain, Fatigue Triad]
D --> Q[Resolution Failure]
Q --> R[Low Omega-3/SPMs]
Q --> S[Cortisol Resistance]
S --> T[Loss of Anti-inflammatory Brake]
T --> D
style D fill:#ff6b6b
style P fill:#4ecdc4
style T fill:#ffe66d
Core concept for cPNI practice: Chronic inflammation is the unifying mechanism underlying modern chronic disease epidemics. It represents the common final pathway where evolutionary mismatch (processed food, sedentary behavior, chronic stress, environmental toxins) meets vulnerable biological systems designed for intermittent activation.
Patient presentations:
- Triad of depression, chronic pain, and chronic fatigue syndrome: The 2022 Miller & Raison model (Nature) shows these aren't separate disorders but manifestations of inflammatory disruption of reward circuits, pain modulation, and energy metabolism
- Metabolic patients: Anyone with insulin resistance, Type 2 Diabetes, obesity, fatty liver, or cardiovascular disease—inflammation both drives and results from metabolic dysfunction
- Autoimmune conditions: Rheumatoid arthritis, psoriasis, inflammatory bowel disease—but also subclinical autoimmunity with elevated antibodies and low-grade symptoms
- Unexplained symptoms: Patients with normal conventional labs but persistent malaise, brain fog, pain—often have CRP 2-5 mg/L (subclinical but significant)
- Treatment-resistant depression: 30-40% of patients don't respond to SSRIs—many have elevated IL-6 and respond to anti-inflammatory interventions
Metamodel connections:
- Metamodel 1 (Intermittent Living): Chronic inflammation reflects loss of oscillation—immune system stuck "on" without recovery periods
- Metamodel 3 (Selfish Systems): The selfish immune system prioritizes survival over reproduction/repair, commandeering resources from brain, muscle, bone
- Evolutionary mismatch: Ancestral immune programs designed for acute pathogen exposure now activated 24/7 by novel triggers (refined carbohydrates, industrial seed oils, chronic psychological stress)
Clinical thresholds:
- CRP >3 mg/L indicates chronic inflammatory state (cardiovascular risk doubles)
- IL-6 >10 pg/mL associated with depression, cognitive decline
- Ferritin >200 ng/mL (women) or >300 ng/mL (men) suggests inflammation (ferritin is acute phase protein)
- Neutrophil-lymphocyte ratio >3:1 indicates immune activation
- HbA1c >5.7% reflects metabolic inflammation even in "prediabetic" range
Intervention framework:
- Remove triggers: Address gut dysbiosis (test/treat SIBO, restore diversity), eliminate gluten if antibodies present, reduce AGEs (avoid high-heat cooking), manage chronic stress
- Support resolution: Omega-3 supplementation (EPA 2-4g/day), Specialized pro-resolving mediators precursors, ensure adequate Vitamin D (>40 ng/mL)
- Restore metabolic flexibility: Time-restricted eating, Intermittent fasting, resistance training (myokines shift to anti-inflammatory profile)
- Enhance vagal tone: Breathing exercises, Cold exposure, Meditation—activate cholinergic anti-inflammatory pathway
- Address HPA axis dysfunction: Normalize Cortisol rhythm, restore receptor sensitivity with Ashwagandha, Phosphatidylserine
Critical insight: You cannot resolve chronic inflammatory conditions by adding anti-inflammatory supplements alone. Resolution requires removing persistent triggers AND actively supporting resolution pathways AND restoring metabolic/neuroendocrine function. The insular cortex dysfunction explains why addressing inflammation improves seemingly unrelated symptoms—because the insula integrates all homeostatic signals.
- Defined by duration >3 weeks and CRP persistently >3 mg/L, often with normal white blood cell count
- Modern epidemic: estimated 60% of deaths worldwide attributable to chronic inflammatory diseases (WHO)
- The cytokine triad: IL-6, TNF, and IL-1β are the primary drivers, with IL-6 as master regulator of acute phase response
- Adipose tissue is not inert storage—visceral fat produces 30% of circulating IL-6 in obese individuals
- Inflammatory cascade disrupts neurotransmitter synthesis: IDO activation reduces serotonin by 40-60% in depressed patients with high CRP
- Insular cortex receives 13 of 15 health-determining behavioral/physiological inputs—explains symptom diversity when inflammation impairs insula function
- Cortisol resistance develops with chronic elevation: receptor downregulation means anti-inflammatory glucocorticoid signaling fails despite normal/high cortisol
- Resolution requires active lipid mediators (Resolvins, Protectins, Maresins)—it's not passive; Western diets lack omega-3 precursors
- Chronic inflammation costs 20% basal metabolic rate—persistent immune activation diverts energy from brain, reproduction, repair
- LPS from gut bacteria can increase 2-3 fold after high-fat Western meal—postprandial endotoxemia drives low-grade inflammation
- Every 1 mg/L increase in CRP associated with 25% increased depression risk (meta-analysis, 45,000+ patients)
- Skeletal muscle IL-6 has dual role: acute exercise-induced IL-6 is anti-inflammatory (transient, enhances insulin sensitivity), chronic elevation is pathological
- acute inflammation — proper inflammatory response that resolves within days; chronic inflammation is failed resolution
- resolution of inflammation — active biochemical program requiring SPMs; absence causes chronic inflammation
- Specialized pro-resolving mediators — resolvins, protectins, maresins required to terminate inflammation; deficiency perpetuates chronicity
- IL-6 — master cytokine in chronic inflammation; drives CRP synthesis, causes insulin resistance, disrupts dopamine signaling
- TNF — central to chronic inflammatory cascade; causes endothelial dysfunction, muscle catabolism, promotes insulin resistance
- IL-1β — inflammasome product that amplifies inflammatory response; key mediator of sickness behaviour and depression
- IFN-γ — drives IDO activation and kynurenine pathway; maintains M1 macrophages polarization in chronic state
- CRP — acute phase protein synthesized in response to IL-6; >3 mg/L indicates chronic inflammatory state
- insular cortex — integrates peripheral inflammatory signals; dysfunction from chronic inflammation explains diverse symptom presentation
- depression — inflammatory subtype driven by IL-6, TNF, IL-1β disrupting monoamine synthesis and dopaminergic pathways
- chronic pain — neuroinflammation and peripheral sensitization maintain pain independent of tissue damage
- chronic fatigue syndrome — inflammatory disruption of mitochondrial function and hypothalamic regulation; IL-6 >5 pg/mL common
- Metabolic syndrome — bidirectional relationship with inflammation; adipose tissue produces cytokines, cytokines worsen insulin resistance
- insulin resistance — both cause and consequence; TNF and IL-6 impair insulin signaling via JNK activation
- neuroinflammation — peripheral cytokines activate microglia, impair BDNF, disrupt neurotransmitter synthesis
- gut dysbiosis — major source of chronic LPS exposure; Akkermansia-muciniphila depletion worsens barrier function
- chronic stress — activates HPA axis, causes Cortisol resistance, primes immune system toward inflammatory state
- visceral adipose tissue — metabolically active endocrine organ secreting IL-6, TNF, adipokines
- cardiovascular disease — atherosclerosis is inflammatory disease; CRP >2 mg/L doubles risk even with normal cholesterol
- neurodegeneration — chronic inflammation accelerates Alzheimer's Disease via microglia activation and tau phosphorylation
- HPA axis — chronic activation leads to Cortisol resistance; loss of anti-inflammatory glucocorticoid signaling perpetuates inflammation
- blood-brain barrier — dysfunction from chronic inflammation allows cytokine entry, amplifying neuroinflammation
- Omega-3 fatty acids — EPA and DHA are precursors for SPMs; deficiency impairs resolution capacity
- NF-κB — master transcription factor for inflammatory genes; chronically activated in metabolic and autoimmune disease
- NLRP3 inflammasome — sensor of metabolic stress (AGEs, cholesterol crystals, glucose) and microbial products; produces IL-1β
- Vagus nerve — anti-inflammatory via cholinergic anti-inflammatory pathway; low HRV associated with elevated CRP
- IDO — enzyme activated by IFN-γ shunting tryptophan to kynurenine; depletes serotonin, produces neurotoxic metabolites
- Top-Down Control — prefrontal regulation of limbic system impaired by inflammatory disruption of glutamatergic signaling
- sickness behaviour — adaptive acute response (fever, fatigue, anhedonia) becomes maladaptive when chronic; mediated by IL-1β